Evidence map›Paper›PMID 26479925›Full record

ArticleNature medicine2015

Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.

Zhen-Zhong Xu, Yong Ho Kim, Sangsu Bang, Yi Zhang, Temugin Berta, Fan Wang, Seog Bae Oh, Ru-Rong Ji

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 206 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed, 1 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 1 synthesis or guideline pooled it, 345 citations in OpenAlex.

  1. Enterochromaffin Cells: Sentinels to Gut Microbiota in Hyperalgesia?Frontiers in cellular and infection microbiology · 2021
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Neuroimmune interactions in cardiovascular homeostasis and disease.American journal of physiology. Cell physiology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Zhen-Zhong XuDepartment of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
Yong Ho KimDepartment of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
Sangsu BangDepartment of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
Yi ZhangDepartment of Neurobiology, Duke University Medical Center, Durham, North Carolina, USA.
Temugin BertaDepartment of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
Fan WangDepartment of Neurobiology, Duke University Medical Center, Durham, North Carolina, USA.
Seog Bae OhPain Cognitive Function Research Center, Dental Research Institute and Department of Neurobiology and Physiology, School of Dentistry, Seoul National University, Seoul, Republic of Korea.
Ru-Rong JiDepartment of Anesthesiology, Duke University Medical Center, Durham, North Carolina, USA.
Duke Medical Center · USDuke University · USDuke University Hospital · USSeoul National University · KR

Funding

Neuronal and glial interactions of neuropathic painR01DE017794 · NIDCR · DUKE UNIVERSITY · PI BUCHHEIT, THOMAS · 2006 to 2021
$6.6M
Resolvins, protectins, and chronic pain resolution.R01NS067686 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG, SERHAN, CHARLES NICHOLAS · 2009 to 2013
$2.8M
Control of trigeminal touch sensory circuit assemblyR01DE019440 · NIDCR · DUKE UNIVERSITY · PI WANG, FAN · 2009 to 2013
$2.2M
Hemichannels, Astrocytic Release, and Neuropathic PainR01DE022743 · NIDCR · DUKE UNIVERSITY · PI JI, RU-RONG, NEDERGAARD, MAIKEN · 2012 to 2016
$2.0M
Resolution pathway of painR01NS087988 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG · 2014 to 2018
$1.7M
Development of novel therapeutics for pain and itch reliefR01NS089479 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG, LEE, SEOK-YONG · 2014 to 2017
$964k
Treating chemotherapy-induced neuropathic pain by targeted silencing of A-fibersR21NS091779 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG · 2015 to 2016
$437k
Resolution of chemotherapy-induced peripheral neuropathy by novel lipid mediatorR21NS082985 · NINDS · DUKE UNIVERSITY · PI XU, ZHEN-ZHONG · 2013 to 2014
$430k
NIDCR NIH HHS R01 DE017794NIDCR NIH HHS R01 DE019440NIDCR NIH HHS R01 DE022743NIDCR NIH HHS R01 DE17794NIDCR NIH HHS R01 DE19440NIDCR NIH HHS R01 DE22743NINDS NIH HHS R01 NS067686NINDS NIH HHS R01 NS087988NINDS NIH HHS R01 NS089479NINDS NIH HHS R01 NS67686NINDS NIH HHS R01 NS87988NINDS NIH HHS R01 NS89479NINDS NIH HHS R21 NS082985NINDS NIH HHS R21 NS091779NINDS NIH HHS R21 NS82985NINDS NIH HHS R21 NS91779
6 · The paper itself

Abstract

Mechanical allodynia, induced by normally innocuous low-threshold mechanical stimulation, represents a cardinal feature of neuropathic pain. Blockade or ablation of high-threshold, small-diameter unmyelinated group C nerve fibers (C-fibers) has limited effects on mechanical allodynia. Although large, myelinated group A fibers, in particular Aβ-fibers, have previously been implicated in mechanical allodynia, an A-fiber-selective pharmacological blocker is still lacking. Here we report a new method for targeted silencing of A-fibers in neuropathic pain. We found that Toll-like receptor 5 (TLR5) is co-expressed with neurofilament-200 in large-diameter A-fiber neurons in the dorsal root ganglion (DRG). Activation of TLR5 with its ligand flagellin results in neuronal entry of the membrane-impermeable lidocaine derivative QX-314, leading to TLR5-dependent blockade of sodium currents, predominantly in A-fiber neurons of mouse DRGs. Intraplantar co-application of flagellin and QX-314 (flagellin/QX-314) dose-dependently suppresses mechanical allodynia after chemotherapy, nerve injury, and diabetic neuropathy, but this blockade is abrogated in Tlr5-deficient mice. In vivo electrophysiology demonstrated that co-application of flagellin/QX-314 selectively suppressed Aβ-fiber conduction in naive and chemotherapy-treated mice. TLR5-mediated Aβ-fiber blockade, but not capsaicin-mediated C-fiber blockade, also reduced chemotherapy-induced ongoing pain without impairing motor function. Finally, flagellin/QX-314 co-application suppressed sodium currents in large-diameter human DRG neurons. Thus, our findings provide a new tool for targeted silencing of Aβ-fibers and neuropathic pain treatment.

Indexed as

AdultAgedAnesthetics, LocalAnimalsAntineoplastic AgentsCapsaicinDiabetic NeuropathiesFemaleFlagellinGanglia, SpinalHumansHyperalgesiaLidocaineMaleMiceMice, KnockoutAnesthetics, LocalAntineoplastic AgentsCapsaicinFlagellinLidocaineneurofilament protein HNeurofilament ProteinsPaclitaxelQX-314Sensory System AgentsToll-Like Receptor 5

Identifiers

PMID26479925
PMCPMC4752254
OpenAlexW2152963050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.